Compare CDMOs with EMA GMP certification for EU-market pharmaceutical manufacturing. Filter by product type, member state, and manufacturing capabilities.
351 companies listed
Germany
AXOlabs is an integrated CRO/CDMO specializing in nucleic acid therapeutics (oligonucleotides). Their platform spans from discovery (lead identification and chemistry optimization using bioinformatics-driven design and high-throughput screening) through preclinical safety/PK studies and GLP-compliant bioanalysis to GMP-compliant manufacturing of ASOs, siRNAs, sgRNAs, aptamers, and bioconjugates for clinical phases I-III and initial commercial supply. AXOlabs operates dual-site, globally integrated facilities in Petaluma, California (USA) and Berlin/Kulmbach (Germany), equipped with Cytiva OligoPilot, OligoProcess, and Asahi Kasei THESYS platforms. The company partners with Codexis on enzymatic RNA manufacturing and with Asahi Kasei on oligonucleotide production technologies.
France
Axyntis is the independent leader of the fine chemical sector in France, operating as a CDMO for pharmaceutical APIs and intermediates. Founded in 2007, the group has multiple manufacturing sites in France including Orgapharm (Pithiviers), Centipharm (Grasse), and Steiner (Saint-Marcel). They produce active pharmaceutical ingredients including about 20 generic APIs with regulatory support (DMF and CEP), as well as specialty chemistry intermediates. Axyntis operates under cGMP conditions with quality assurance and regulatory affairs oversight, offering services from laboratory through pilot to industrial production scale, including preparative chromatography and hydrogenation.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.